Evaluation of CX3CR1 gene DNA methylation in developmental dysplasia of the hip (DDH)

[1]  R. Shirkoohi,et al.  DNA hypermethylation of GDF5 in developmental dysplasia of the hip (DDH) , 2019, Molecular genetics & genomic medicine.

[2]  N. Maffulli,et al.  Genetics in orthopaedic practice. , 2019, Journal of biological regulators and homeostatic agents.

[3]  S. Basit,et al.  Whole genome SNP genotyping in a family segregating developmental dysplasia of the hip detected runs of homozygosity on chromosomes 15q13.3 and 19p13.2 , 2018, Congenital anomalies.

[4]  J. Parvizi,et al.  A murine model for developmental dysplasia of the hip: ablation of CX3CR1 affects acetabular morphology and gait , 2017, Journal of Translational Medicine.

[5]  M. Mahmoudi,et al.  Promoter hypermethylation of BCL11B gene correlates with downregulation of gene transcription in ankylosing spondylitis patients , 2017, Genes and Immunity.

[6]  M. Mahmoudi,et al.  Epigenetic involvement in etiopathogenesis and implications in treatment of systemic lupus erythematous , 2017, Inflammation Research.

[7]  M. Mahmoudi,et al.  New insights toward the pathogenesis of ankylosing spondylitis; genetic variations and epigenetic modifications , 2017, Modern rheumatology.

[8]  M. Javan,et al.  Epigenetic Modifications and Therapy in Multiple Sclerosis , 2017, NeuroMolecular Medicine.

[9]  B. Shaw,et al.  Evaluation and Referral for Developmental Dysplasia of the Hip in Infants , 2016, Pediatrics.

[10]  M. Garshasbi,et al.  Evaluation of DNMT1 gene expression profile and methylation of its promoter region in patients with ankylosing spondylitis , 2016, Clinical Rheumatology.

[11]  V. Somers,et al.  Detection of novel diagnostic antibodies in ankylosing spondylitis: An overview. , 2016, Autoimmunity reviews.

[12]  M. Mahmoudi,et al.  Epigenetic alterations underlying autoimmune diseases , 2016, Autoimmunity.

[13]  Ruth R. Montgomery,et al.  DNA Methylation Regulates the Differential Expression of CX3CR1 on Human IL-7Rαlow and IL-7Rαhigh Effector Memory CD8+ T Cells with Distinct Migratory Capacities to the Fractalkine , 2015, The Journal of Immunology.

[14]  E. Ballestar,et al.  Gains of DNA methylation in myeloid terminal differentiation are dispensable for gene silencing but influence the differentiated phenotype , 2015, The FEBS journal.

[15]  Kishore Mulpuri,et al.  Detection and Nonoperative Management of Pediatric Developmental Dysplasia of the Hip in Infants up to Six Months of Age. , 2015, The Journal of the American Academy of Orthopaedic Surgeons.

[16]  J. Parvizi,et al.  Linkage mapping and whole exome sequencing identify a shared variant in CX3CR1 in a large multi-generation family. , 2014, The Journal of arthroplasty.

[17]  Mark A. Levenstien,et al.  Developmental Dysplasia of the Hip: Linkage Mapping and Whole Exome Sequencing Identify a Shared Variant in CX3CR1 in All Affected Members of a Large Multigeneration Family , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  K. Matsushima,et al.  Roles of chemokine receptor CX3CR1 in maintaining murine bone homeostasis through the regulation of both osteoblasts and osteoclasts , 2013, Journal of Cell Science.

[19]  Peter A. Jones.  Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.

[20]  H. Nawaz,et al.  Developmental dysplasia of the hip , 2010, Orthopedic reviews.

[21]  P. Allavena,et al.  Human glioma tumors express high levels of the chemokine receptor CX3CR1. , 2010, European cytokine network.

[22]  D. Viskochil,et al.  Familial Predisposition to Developmental Dysplasia of the Hip , 2009, Journal of pediatric orthopedics.

[23]  N. Maffulli,et al.  Fibrillin 1 gene with R2726W mutation is absent in patients with primary protrusio acetabuli and developmental dysplasia of the hip. , 2009, Medical science monitor : international medical journal of experimental and clinical research.

[24]  N. Maffulli,et al.  Vitamin D and oestrogen receptor polymorphisms in developmental dysplasia of the hip and primary protrusio acetabuli – A preliminary study , 2007, Journal of Negative Results in BioMedicine.

[25]  F. Canovas,et al.  Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes , 2007, Arthritis research & therapy.

[26]  P. Lapunzina,et al.  Risks of congenital anomalies in large for gestational age infants. , 2002, The Journal of pediatrics.

[27]  M. Berant,et al.  Developmental Dysplasia of the Hip: A New Approach to Incidence , 1999, Pediatrics.

[28]  E. Haan,et al.  Perinatal risk factors for developmental dysplasia of the hip , 1997, Archives of disease in childhood. Fetal and neonatal edition.

[29]  S. Tredwell.  Neonatal screening for hip joint instability. Its clinical and economic relevance. , 1992, Clinical orthopaedics and related research.

[30]  W. G. Cole.  Screening for congenital dislocation of the hip in Australia , 1991, Journal of paediatrics and child health.

[31]  S. Weinstein.  Natural history of congenital hip dislocation (CDH) and hip dysplasia. , 1987, Clinical orthopaedics and related research.

[32]  N. Wald,et al.  CONGENITAL TALIPES AND HIP MALFORMATION IN RELATION TO AMNIOCENTESIS: A CASE-CONTROL STUDY , 1983, The Lancet.

[33]  J. Hawnaur,et al.  REASONS FOR LATE DETECTION OF HIP DISLOCATION IN CHILDHOOD , 1983, The Lancet.

[34]  A. Rehm,et al.  Should all twins and multiple births undergo ultrasound examination for developmental dysplasia of the hip?: A retrospective study of 990 multiple births. , 2013, The bone & joint journal.

[35]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[36]  T. C. Howard,et al.  The Otto Aufranc Award Paper. Infant hip screening. , 1982, The Hip.

[37]  G. T.  EARLY DIAGNOSIS AND TREATMENT OF CONGENITAL DISLOCATION OF THE HIP * , 2022 .